Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pragmatic EE-PRS Statin Trial
2024-513424-42-01Phase 4Authorised
- Sponsor
- University of Tartu
- Start
- Dec 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of atorvastatin and rosuvastatin in coronary arteriosclerosis and cardiac morbidity (2 arms), sponsored by University of Tartu. Planned start Dec 2024; status: authorised.
02
Drugs
atorvastatinrosuvastatin
03
Conditions
coronary arteriosclerosiscardiac morbidity
Beyond the preview
Go deeper on 2024-513424-42-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-513424-42-01.